765 filings
Page 5 of 39
8-K
OGEN
Oragenics Inc
22 Dec 22
Oragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate
9:00am
8-K
OGEN
Oragenics Inc
20 Dec 22
Oragenics, Inc. Receives NYSE American Notice
4:55pm
8-K
OGEN
Oragenics Inc
19 Dec 22
Oragenics, Inc. Announces New Chair
4:51pm
4
OGEN
Oragenics Inc
16 Dec 22
ORAGENICS / ROBERT C KOSKI ownership change
4:05pm
8-K
OGEN
Oragenics Inc
16 Dec 22
Departure of Directors or Certain Officers
4:05pm
4
Robert C Koski
15 Dec 22
ORAGENICS / ROBERT C KOSKI ownership change
4:15pm
4
Robert C Koski
12 Dec 22
ORAGENICS / ROBERT C KOSKI ownership change
4:22pm
4
Robert C Koski
9 Dec 22
ORAGENICS / ROBERT C KOSKI ownership change
4:14pm
4
Robert C Koski
1 Dec 22
ORAGENICS / ROBERT C KOSKI ownership change
4:08pm
8-K
OGEN
Oragenics Inc
16 Nov 22
Departure of Directors or Certain Officers
4:15pm
10-Q
2022 Q3
OGEN
Oragenics Inc
Quarterly report
14 Nov 22
4:34pm
DEF 14A
OGEN
Oragenics Inc
Definitive proxy
31 Oct 22
4:00pm
8-K
OGEN
Oragenics Inc
3 Oct 22
Regulation FD Disclosure
9:15am
PRE 14A
OGEN
Oragenics Inc
Preliminary proxy
30 Sep 22
4:00pm
8-K
OGEN
Oragenics Inc
30 Sep 22
Oragenics Issues Letter to Shareholders
9:00am
8-K
OGEN
Oragenics Inc
24 Aug 22
Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate
8:02am
10-Q
2022 Q2
OGEN
Oragenics Inc
Quarterly report
9 Aug 22
12:00am
UPLOAD
OGEN
Oragenics Inc
8 Aug 22
Letter from SEC
12:00am
8-K
OGEN
Oragenics Inc
3 Aug 22
Departure of Directors or Certain Officers
4:05pm
4
OGEN
Oragenics Inc
2 Aug 22
ORAGENICS / ROBERT C KOSKI ownership change
4:42pm